BAA contract titled, "validating human stem cell cardiomyocyte technology for better predictive assessment of drug-induced cardiac toxicity."
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201510107C
- Awardee
-
Health And Environmental Sciences Institute UEI PS4UVEN825F3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $267,658
Award facts
- Opportunity
-
- FDABAA1500121 Solicitation number
- Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science Award Notice · Posted Feb 23, 2015
- Contract value 100% obligated
- $267,658.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20005, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $132,746 | |
| Original award | $134,912 |
About this award
This is a federal contract award from the Food and Drug Administration (FDA) to the Health and Environmental Sciences Institute (HESI), a non-profit organization. The contract, worth $267,658.00, is for a project titled "VALIDATING HUMAN STEM CELL CARDIOMYOCYTE TECHNOLOGY FOR BETTER PREDICTIVE ASSESSMENT OF DRUG-INDUCED CARDIAC TOXICITY." The contract is a definitive contract with a firm fixed price. This contract appears to be supporting the FDA's efforts to evaluate the reliability of in vitro assays for drug safety and efficacy. HESI has received other prime federal contract awards and grants from the FDA to conduct research in areas like assessing the variability and reproducibility of manual and automated patch clamp platforms, as well as evaluating the reproducibility of the TGX-DDI transcriptomic biomarker method for genotoxicity testing. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSF223201510107C?
HHSF223201510107C was awarded to Health And Environmental Sciences Institute by Food and Drug Administration (Department of Health and Human Services) on August 30, 2015.
How much is contract HHSF223201510107C worth?
The government has obligated $267,658 on HHSF223201510107C.
Was contract HHSF223201510107C competed?
The extent of competition for HHSF223201510107C was full and open competition. The government received 7 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award